# Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120

> **NCT02489513** · PHASE1 · COMPLETED · sponsor: **Agios Pharmaceuticals, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]-AG-120

## Key facts

- **NCT ID:** NCT02489513
- **Lead sponsor:** Agios Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02489513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02489513, "Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02489513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*